Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1980
[Evaluation of the presence of warfarin-resistant rats in the city of Reggio Calabria]
P Alessandroni, S Marchini, A Bernardo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 1, 1996
Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy
S Cascinu, V Casadei, E Del Ferro, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1982
Social grooming in Macaca fuscata
P G Turillazzi, S Marchini, P Alessandroni, et al.
Oncology
|
September 1, 1995
Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia
S Cascinu, E Del Ferro, A Fedeli, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer
S Cascinu, P Alessandroni, D Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 16, 1998
Different doses of pamidronate in patients with painful osteolytic bone metastases
S Cascinu, F Graziano, P Alessandroni, et al.
Minerva Medica
|
September 11, 2002
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer
D Rossi, F Graziano, S Luzi Fedeli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 7, 2000
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer
C Massacesi, R Bascioni, R Cellerino, et al.
Anticancer Research
|
January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study
D Rossi, F Graziano, V Catalano, et al.
World Journal of Oncology
|
November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
D Rossi, B Pistilli, D Morale, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1980
[Evaluation of the presence of warfarin-resistant rats in the city of Reggio Calabria]
P Alessandroni, S Marchini, A Bernardo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 1, 1996
Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy
S Cascinu, V Casadei, E Del Ferro, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1982
Social grooming in Macaca fuscata
P G Turillazzi, S Marchini, P Alessandroni, et al.
Oncology
|
September 1, 1995
Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia
S Cascinu, E Del Ferro, A Fedeli, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer
S Cascinu, P Alessandroni, D Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 16, 1998
Different doses of pamidronate in patients with painful osteolytic bone metastases
S Cascinu, F Graziano, P Alessandroni, et al.
Minerva Medica
|
September 11, 2002
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer
D Rossi, F Graziano, S Luzi Fedeli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 7, 2000
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer
C Massacesi, R Bascioni, R Cellerino, et al.
Anticancer Research
|
January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study
D Rossi, F Graziano, V Catalano, et al.
World Journal of Oncology
|
November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
D Rossi, B Pistilli, D Morale, et al.
Page
of 3